Mechanism of fibroblast growth factor-binding protein 1 repression by TGF-β

Biochemical and Biophysical Research Communications

Volumn 345, Issue 2, 2006, Pages 595-601

  Briones, Victorino R ^a   Chen, Shiyou ^a   Riegel, Anna Tate ^a   Lechleider, Robert J ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Fibroblast growth factor binding protein 1; Signal transduction; Smad; Transcriptional regulation; Transforming growth factor

Indexed keywords

BINDING PROTEIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR BINDING PROTEIN 1; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; IN VITRO STUDY; MESENCHYME CELL; METHYLATION; MOUSE; NEURAL CREST CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL DIFFERENTIATION; DNA METHYLATION; DNA-BINDING PROTEINS; EXTRACELLULAR MATRIX PROTEINS; FIBROBLAST GROWTH FACTORS; GENE SILENCING; HUMANS; MUSCLE, SMOOTH; PROMOTER REGIONS (GENETICS); RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33646830130     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.04.052     Document Type: Article

References (34)

1. Papetti M., and Herman I.M. Mechanisms of normal and tumor-derived angiogenesis. Am. J. Physiol. Cell Physiol. 282 (2002) C947-C970
2. Bergers G., and Song S. The role of pericytes in blood-vessel formation and maintenance. Neurooncol 7 (2005) 452-464
3. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6 (2000) 389-395
4. Carmeliet P., and Collen D. Transgenic mouse models in angiogenesis and cardiovascular disease. J. Pathol. 190 (2000) 387-405
5. Kurtz A., Aigner A., Cabal-Manzano R.H., Butler R.E., Hood D.R., Sessions R.B., Czubayko F., and Wellstein A. Differential regulation of a fibroblast growth factor-binding protein during skin carcinogenesis and wound healing. Neoplasia 6 (2004) 595-602
6. Newby A.C., and Zaltsman A.B. Molecular mechanisms in intimal hyperplasia. J. Pathol. 190 (2000) 300-309
7. Intengan H.D., and Schiffrin E.L. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 38 (2001) 581-587
8. Chang H., Brown C.W., and Matzuk M.M. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr. Rev. 23 (2002) 787-823
9. Seki T., Hong K.H., and Oh S.P. Nonoverlapping expression patterns of ALK1 and ALK5 reveal distinct roles of each receptor in vascular development. Lab. Invest. (2005)
10. Chen S., and Lechleider R.J. Transforming growth factor-beta-induced differentiation of smooth muscle from a neural crest stem cell line. Circ. Res. 94 (2004) 1195-1202
11. Tassi E., Al-Attar A., Aigner A., Swift M.R., McDonnell K., Karavanov A., and Wellstein A. Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding protein. J. Biol. Chem. 276 (2001) 40247-40253
12. Aigner A., Ray P.E., Czubayko F., and Wellstein A. Immunolocalization of an FGF-binding protein reveals a widespread expression pattern during different stages of mouse embryo development. Histochem.Cell Biol. 117 (2002) 1-11
13. Li W.M., and Chen W.B. Effect of FGF-BP on angiogenesis in squamous cell carcinoma. Chin. Med. J. (Engl.) 117 (2004) 621-623
14. Aigner A., Renneberg H., Bojunga J., Apel J., Nelson P.S., and Czubayko F. Ribozyme-targeting of a secreted FGF-binding protein (FGF-BP) inhibits proliferation of prostate cancer cells in vitro and in vivo. Oncogene 21 (2002) 5733-5742
15. Antoine M., Wirz W., Tag C.G., Mavituna M., Emans N., Korff T., Stoldt V., Gressner A.M., and Kiefer P. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells. Growth Factors 23 (2005) 87-95
16. Hirschi K.K., Rohovsky S.A., and D'Amore P.A. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. Cell Biol. 141 (1998) 805-814
17. Harris V.K., Kagan B.L., Ray R., Coticchia C.M., Liaudet-Coopman E.D., Wellstein A., and Riegel A.T. Serum induction of the fibroblast growth factor-binding protein (FGF-BP) is mediated through ERK and p38 MAP kinase activation and C/EBP-regulated transcription. Oncogene 20 (2001) 1730-1738
18. Deltour S., Guerardel C., and Leprince D. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B. Proc. Natl. Acad. Sci. USA 96 (1999) 14831-14836
19. Abuharbeid S., Czubayko F., and Aigner A. The fibroblast growth factor-binding protein FGF-BP. Int. J. Biochem. Cell Biol. (2005)
20. Beer H.D., Bittner M., Niklaus G., Munding C., Max N., Goppelt A., and Werner S. The fibroblast growth factor binding protein is a novel interaction partner of FGF-7, FGF-10 and FGF-22 and regulates FGF activity: implications for epithelial repair. Oncogene 24 (2005) 5269-5277
21. Xie B., Tassi E., Swift M.R., McDonnell K., Bowden E.T., Wang S., Ueda Y., Tomita Y., Riegel A.T., and Wellstein A. Identification of the FGF interacting domain in a secreted FGF-binding protein by phage display. J. Biol. Chem. (2005)
22. Aigner A., Butscheid M., Kunkel P., Krause E., Lamszus K., Wellstein A., and Czubayko F. An FGF-binding protein (FGF-BP) exerts its biological function by parallel paracrine stimulation of tumor cell and endothelial cell proliferation through FGF-2 release. Int. J. Cancer 92 (2001) 510-517
23. Massague J., and Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 19 (2000) 1745-1754
24. ten D.P., Miyazono K., and Heldin C.H. Signaling inputs converge on nuclear effectors in TGF-beta signaling. Trends Biochem. Sci. 25 (2000) 64-70
25. Chen Y.G., Hata A., Lo R.S., Wotton D., Shi Y., Pavletich N., and Massague J. Determinants of specificity in TGF-beta signal transduction. Genes Dev. 12 (1998) 2144-2152
26. Guerardel C., Deltour S., Pinte S., Monte D., Begue A., Godwin A.K., and Leprince D. Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53. J. Biol. Chem. 276 (2001) 3078-3089
27. Deltour S., Pinte S., Guerardel C., Wasylyk B., and Leprince D. The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif. Mol. Cell Biol. 22 (2002) 4890-4901
28. Chinnadurai G. CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol. Cell 9 (2002) 213-224
29. Subramanian T., and Chinnadurai G. Association of class I histone deacetylases with transcriptional corepressor CtBP. FEBS Lett. 540 (2003) 255-258
30. Nibu Y., Zhang H., Bajor E., Barolo S., Small S., and Levine M. dCtBP mediates transcriptional repression by Knirps, Kruppel and Snail in the Drosophila embryo. EMBO J. 17 (1998) 7009-7020
31. Nibu Y., Zhang H., and Levine M. Interaction of short-range repressors with Drosophila CtBP in the embryo. Science 280 (1998) 101-104
32. Turner J., and Crossley M. Cloning and characterization of mCtBP2, a co-repressor that associates with basic Kruppel-like factor and other mammalian transcriptional regulators. EMBO J. 17 (1998) 5129-5140
33. Fox A.H., Liew C., Holmes M., Kowalski K., Mackay J., and Crossley M. Transcriptional cofactors of the FOG family interact with GATA proteins by means of multiple zinc fingers. EMBO J. 18 (1999) 2812-2822
34. van Grunsven L.A., Michiels C., Van de P.T., Nelles L., Wuytens G., Verschueren K., and Huylebroeck D. Interaction between Smad-interacting protein-1 and the corepressor C-terminal binding protein is dispensable for transcriptional repression of E-cadherin. J. Biol. Chem. 278 (2003) 26135-26145